| Training Exposure | No Exposure | Group × time interaction | |||
| Baseline | Post-Training | Baseline | Post-Training | P-Value ** | |
| (N = 15) | (N = 15) | (N = 29) | (N = 29) | ||
| Number of Biopsies | 4.197 | 4.712 | 1.853 | 3.65 | 0.391 |
| Biopsy finding | |||||
| Lesion-specific | 3.353 | 4.175 | 1.335 | 3.573 | 0.286 |
| Benign lesions | 3.353 | 3.746 | 1.113 | 2.847 | 0.303 |
| Malignant lesions | 0 | 0.429 | 0.222 | 0.726 | N/A |
| Melanoma | 0 | 0.109 | 0 | 0 | N/A |
| SCC | 0 | 0.32 | 0.128 | 0.498 | N/A |
| BCC | 0 | 0 | 0.053 | 0.088 | N/A |
| Other skin cancers | 0 | 0 | 0.041 | 0 | N/A |
| Rashes / Inflammatory | 0.844 | 0.537 | 0.519 | 0.077 | 0.094 |
Notes: *All rates are calculated based on per 1000 patients. **P values with N/A indicate where models were not run due to small counts or models did not converge.
Abbreviations: BCC- Basal Cell Carcinoma, SCC- Squamous Cell Carcinoma